The Affiliated Cancer Hospital of Shandong First Medical University

Jinan 250117

2 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer — Recruiting now
• A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) — Recruiting now